336 related articles for article (PubMed ID: 36153665)
1. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review.
Pasieka JL; Wentworth K; Yeo CT; Cremers S; Dempster D; Fukumoto S; Goswami R; Houillier P; Levine MA; Pasternak JD; Perrier ND; Sitges-Serra A; Shoback DM
J Bone Miner Res; 2022 Dec; 37(12):2586-2601. PubMed ID: 36153665
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA; Rubin MR; Schwarz P; Vokes T; Shoback DM; Gagnon C; Palermo A; Marcocci C; Clarke BL; Abbott LG; Hofbauer LC; Kohlmeier L; Pihl S; An X; Eng WF; Smith AR; Ukena J; Sibley CT; Shu AD; Rejnmark L
J Bone Miner Res; 2023 Jan; 38(1):14-25. PubMed ID: 36271471
[TBL] [Abstract][Full Text] [Related]
3. Management of Hypoparathyroidism.
Khan AA; Guyatt G; Ali DS; Bilezikian JP; Collins MT; Dandurand K; Mannstadt M; Murphy D; M'Hiri I; Rubin MR; Sanders R; Shrayyef M; Siggelkow H; Tabacco G; Tay YD; Van Uum S; Vokes T; Winer KK; Yao L; Rejnmark L
J Bone Miner Res; 2022 Dec; 37(12):2663-2677. PubMed ID: 36161671
[TBL] [Abstract][Full Text] [Related]
4. Hypoparathyroidism: Genetics and Diagnosis.
Mannstadt M; Cianferotti L; Gafni RI; Giusti F; Kemp EH; Koch CA; Roszko KL; Yao L; Guyatt GH; Thakker RV; Xia W; Brandi ML
J Bone Miner Res; 2022 Dec; 37(12):2615-2629. PubMed ID: 36375809
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.
Puliani G; Hasenmajer V; Simonelli I; Sada V; Pofi R; Minnetti M; Cozzolino A; Napoli N; Pasqualetti P; Gianfrilli D; Isidori AM
J Bone Miner Res; 2022 Jul; 37(7):1233-1250. PubMed ID: 35485213
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.
Khan AA; Bilezikian JP; Brandi ML; Clarke BL; Gittoes NJ; Pasieka JL; Rejnmark L; Shoback DM; Potts JT; Guyatt GH; Mannstadt M
J Bone Miner Res; 2022 Dec; 37(12):2568-2585. PubMed ID: 36054621
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ye Z; Silverberg SJ; Sreekanta A; Tong K; Wang Y; Chang Y; Zhang M; Guyatt G; Tangamornsuksun W; Zhang Y; Manja V; Bakaa L; Couban RJ; Brandi ML; Clarke B; Khan AA; Mannstadt M; Bilezikian JP
J Bone Miner Res; 2022 Nov; 37(11):2351-2372. PubMed ID: 36053960
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid Hormone Therapy for Managing Chronic Hypoparathyroidism: A Systematic Review and Meta-Analysis.
Yao L; Li J; Li M; Lin C; Hui X; Tamilselvan D; Kandi M; Sreekanta A; Makhdami N; Ali DS; Dandurand K; Yang K; Bilezikian JP; Brandi ML; Clarke BL; Mannstadt M; Rejnmark L; Khan AA; Guyatt G
J Bone Miner Res; 2022 Dec; 37(12):2654-2662. PubMed ID: 36385517
[TBL] [Abstract][Full Text] [Related]
9. Hypoparathyroidism.
Bilezikian JP
J Clin Endocrinol Metab; 2020 Jun; 105(6):1722-36. PubMed ID: 32322899
[TBL] [Abstract][Full Text] [Related]
10. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
[TBL] [Abstract][Full Text] [Related]
11. Applicability of intraoperative parathyroid hormone assay during total thyroidectomy as a guide for the surgeon to selective parathyroid tissue autotransplantation.
Barczyński M; Cichoń S; Konturek A; Cichoń W
World J Surg; 2008 May; 32(5):822-8. PubMed ID: 18246390
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label Study.
Ish-Shalom S; Caraco Y; Khazen NS; Gershinsky M; Szalat A; Schwartz P; Arbit E; Galitzer H; Tang JC; Burshtein G; Rothner A; Raskin A; Blum M; Fraser WD
J Bone Miner Res; 2021 Jun; 36(6):1060-1068. PubMed ID: 33666947
[TBL] [Abstract][Full Text] [Related]
13. Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long-Acting PTH.
Sato T; Verma S; Khatri A; Dean T; Goransson O; Gardella TJ; Wein MN
JBMR Plus; 2021 May; 5(5):e10441. PubMed ID: 33977197
[TBL] [Abstract][Full Text] [Related]
14. Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism.
Yao L; Guyatt G; Ye Z; Bilezikian JP; Brandi ML; Clarke BL; Mannstadt M; Khan AA
J Bone Miner Res; 2022 Nov; 37(11):2404-2410. PubMed ID: 36053800
[TBL] [Abstract][Full Text] [Related]
15. Postsurgical Hypoparathyroidism: A Systematic Review.
Kakava K; Tournis S; Papadakis G; Karelas I; Stampouloglou P; Kassi E; Triantafillopoulos I; Villiotou V; Karatzas T
In Vivo; 2016; 30(3):171-9. PubMed ID: 27107072
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of Hypoparathyroidism].
Michigami T
Clin Calcium; 2016 Jun; 26(6):831-8. PubMed ID: 27230838
[TBL] [Abstract][Full Text] [Related]
17. Postoperative hypoparathyroidism: medical and surgical therapeutic options.
Walker Harris V; Jan De Beur S
Thyroid; 2009 Sep; 19(9):967-73. PubMed ID: 19731978
[TBL] [Abstract][Full Text] [Related]
18. Post-thyroidectomy hypoparathyroidism, what should we keep in mind?
Caglià P; Puglisi S; Buffone A; Bianco SL; Okatyeva V; Veroux M; Cannizzaro MA
Ann Ital Chir; 2017; 6():371-381. PubMed ID: 29197191
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders.
Schneider AB; Sherwood LM
Metabolism; 1975 Jul; 24(7):871-98. PubMed ID: 166271
[TBL] [Abstract][Full Text] [Related]
20. Update on hypoparathyroidism.
Cusano NE; Bilezikian JP
Curr Opin Rheumatol; 2019 Jul; 31(4):381-387. PubMed ID: 31107289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
